Literature DB >> 9120447

Dystonia in progressive supranuclear palsy.

C L Barclay1, A E Lang.   

Abstract

OBJECTIVES: To document the nature, distribution, and frequency of dystonic symptoms in progressive supranuclear palsy (PSP).
METHODS: Charts and videotapes of all clinically diagnosed patients with PSP seen between 1983 and 1993 were reviewed and the occurrence, nature, and distribution of all dystonic symptoms were recorded.
RESULTS: Of 83 identified cases 38 had some dystonic features. Twenty (24%) had blepharospasm (one was induced by levodopa), 22 (27%) had limb dystonia (one was induced by electroconvulsive therapy and another by levodopa), 14 (17%) had axial dystonia in extension, one had oromandibular dystonia induced by levodopa, and two had other cranial dystonias. Six patients had limb dystonia as an early or presenting feature, sometimes leading to misdiagnosis of cortical-basal ganglionic degeneration. All three patients who had postmortem confirmation of the diagnosis had other concurrent disease. One patient with bilateral limb dystonia and blepharospasm had evidence of previous hydrocephalus and severe arteriosclerotic changes. One with arm dystonia also had cerebrovascular disease and one with hemidystonia also had rare swollen chromatolytic neurons in the frontotemporal cortex.
CONCLUSIONS: Dystonia is a common manifestation of PSP. Limb dystonia is particularly common and may indicate the presence of concurrent disease. When dystonia occurs in PSP, dopaminergic medication should be cautiously reduced or discontinued to rule out the possibility of treatment induced symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9120447      PMCID: PMC1074090          DOI: 10.1136/jnnp.62.4.352

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings.

Authors:  J Jankovic; D I Friedman; F J Pirozzolo; J A McCrary
Journal:  Adv Neurol       Date:  1990

Review 2.  Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  J Rivest; N Quinn; C D Marsden
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

Review 3.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Eyelid movement abnormalities in progressive supranuclear palsy.

Authors:  L I Golbe; P H Davis; F E Lepore
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

5.  Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons.

Authors:  G Giaccone; F Tagliavini; J S Street; B Ghetti; O Bugiani
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Progressive supranuclear palsy (report of 4 cases with particular reference to blepharospasm and levodopa therapy).

Authors:  S Singh; B H Smith; A Lal
Journal:  Neurol India       Date:  1974-06       Impact factor: 2.117

7.  Blepharospasm in progressive supranuclear palsy: the first case in Thailand.

Authors:  N Khunadorn; R Kalumpaheti; K Saipetara
Journal:  J Med Assoc Thai       Date:  1979-02

Review 8.  Progressive supranuclear palsy.

Authors:  R C Duvoisin; L I Golbe; F E Lepore
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

9.  [2 cases of isolated dystonia of the upper limb as an early sign of Steele-Richardson-Olszewski disease].

Authors:  J M Léger; J A Girault; F Bolgert
Journal:  Rev Neurol (Paris)       Date:  1987       Impact factor: 2.607

10.  Rigidity and dorsiflexion of the neck in progressive supranuclear palsy and the interstitial nucleus of Cajal.

Authors:  J Fukushima-Kudo; K Fukushima; K Tashiro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

View more
  17 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

2.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

3.  Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism.

Authors:  Won Tae Yoon; Eun Joo Chung; Sang Hyeon Lee; Byung Joon Kim; Won Yong Lee
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

Review 4.  Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.

Authors:  I Litvan; D A Grimes; A E Lang; J Jankovic; A McKee; M Verny; K Jellinger; K R Chaudhuri; R K Pearce
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

Review 5.  Dystonia in Parkinson's disease.

Authors:  Eduardo Tolosa; Yaroslau Compta
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 6.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

Review 7.  An Eye on Movement Disorders.

Authors:  Duncan Wilson; Mark Hallett; Tim Anderson
Journal:  Mov Disord Clin Pract       Date:  2021-08-10

Review 8.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

9.  Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.

Authors:  Soyoung Jin; Minyoung Oh; Seung Jun Oh; Jungsu S Oh; Sang Ju Lee; Sun Ju Chung; Chong Sik Lee; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-11-03

10.  Levodopa-induced facial dystonia in a case of progressive supranuclear palsy.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2012-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.